Kuratani Toru
Nihon Geka Gakkai Zasshi. 2014 Mar;115(2):71-5.
Thoracic endovascular aortic repair (TEVAR) for thoracic aortic pathologies has become common worldwide as a less-invasive alternative to open surgery, and satisfactory early outcomes were achieved. However, there have been few reports of mid- and long-term results in this field. In this study, we reviewed the mid- and long-term results of the TEVAR procedure for the treatment of thoracic aortic pathologies. In coming years, there will be intense competition to develop the devices themselves (e.g., branched devices), improve delivery systems, and supplement devices with auxiliary functions. There are high expectations for those next-generation devices and how they will improve and advance treatment methods. Cardiovascular surgeons look forward to the future of hybrid surgery 5 years from now.
作为一种侵入性较小的开胸手术替代方案，胸主动脉腔内修复术（TEVAR）在全球范围内已变得普遍，并取得了令人满意的早期疗效。然而，该领域关于中长期结果的报道较少。在本研究中，我们回顾了TEVAR治疗胸主动脉疾病的中长期结果。在未来几年，开发设备本身（如分支型设备）、改进输送系统以及为设备补充辅助功能将面临激烈竞争。人们对这些下一代设备及其如何改进和推进治疗方法寄予厚望。心血管外科医生期待着从现在起5年后的杂交手术未来。
